Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Axonics Modulation Technologies Inc (AXNX)

49.94   1.42 (2.93%) 10-23 23:35
Open: 49.75 Pre. Close: 48.52
High: 50.29 Low: 48.55
Volume: 360,720 Market Cap: 1,974M
Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The company is headquartered in Irvine, California and currently employs 87 full-time employees. The firm is focused on the design, development, and commercialization of sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). Its rechargeable SNM system (r-SNM System) delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company has two clinical studies relating to its r-SNM System: a European study, RELAX-OAB, and a United States pivotal study, ARTISAN-SNM. SNM therapy consists of two phases: an evaluation period, also called the external trial period, which typically lasts a few days to a few weeks, and a permanent implant for those patients who experience a successful external trial period.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.375 - 50.616 50.616 - 50.835
Low: 47.959 - 48.238 48.238 - 48.492
Close: 49.476 - 49.939 49.939 - 50.359

Technical analysis

as of: 2020-10-23 4:40:56 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 60.85     One year: 71.08
Support: Support1: 44.65    Support2: 40.05
Resistance: Resistance1: 52.10    Resistance2: 60.85
Pivot: 48.58
Moving Average: MA(5): 47.88     MA(20): 48.73
MA(100): 42.05     MA(250): 34.42
MACD: MACD(12,26): 1.05     Signal(9): 1.34
Stochastic oscillator: %K(14,3): 45.75     %D(3): 30.44
RSI: RSI(14): 61.34
52-week: High: 52.10  Low: 15.25  Change(%): 126.0
Average Vol(K): 3-Month: 54153  10-Days: 36553

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AXNX has closed below upper band by 22.6%. Bollinger Bands are 32.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 20 Oct 2020
Axonics launches SNS postmarket study - Mass Device

Tue, 20 Oct 2020
Axonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System - Business Wire

Wed, 14 Oct 2020
Axonics Modulation Technologies Inc. (AXNX) is set to bring smile on the investors face as Analysts sets mean Target price of $52.75 - The InvestChronicle

Mon, 12 Oct 2020
Leerink Partners Stick to Their Buy Rating for Axonics Modulation Technologies - Investing.com

Wed, 07 Oct 2020
Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Winner for Orange County - Business Wire

Wed, 30 Sep 2020
Axonics Modulation Technologies, Inc. (AXNX) investors to reap big returns again - Marketing Sentinel

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 40
Shares Float (M) 33
% Held by Insiders 9.90
% Held by Institutions 102.76
Shares Short (K) 5,790
Shares Short P. Month (K) 5,340

Stock Financials

EPS -2.560
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.550
Profit Margin -155.70
Operating Margin -155.07
Return on Assets (ttm) -20.6
Return on Equity (ttm) -39.8
Qtrly Rev. Growth 922.4
Gross Profit (p.s.) 0.185
Sales Per Share 1.335
EBITDA (p.s.) -2.034
Qtrly Earnings Growth
Operating Cash Flow (M) -88
Levered Free Cash Flow (M) -60

Stock Valuations

PE Ratio -19.51
PEG Ratio
Price to Book value 6.61
Price to Sales 37.41
Price to Cash Flow -22.35

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.